Main content

    Kidney Transplant

    Kidney and Pancreas Transplant Program

    Adult Clinical Trials Main Page

    Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
    Principal Investigator:
    Ram Peddi, MD

    Contact:
    Jennifer Wilson
    415-600-1155
    Email WilsonJX@cpmcri.org
    		 A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients with BK Virus Nephropathy-NCT00138424
    Visit the Cidofovir in Renal Transplant Recipients With BKVN on ClinicalTrials.gov.     		Kidney transplant recipients who have been diagnosed with BK Virus Nephropathy Open
    Principal Investigator:
    Ram Peddi, MD

    Contact:
    Jennifer Wilson
    415-600-1155
    Email WilsonJX@cpmcri.org    		 A Pilot Study to Evaluate the Safety and Efficacy of Mycophenolate Sodium (Myfortic®) in Combination with Sirolimus (Rapamune®) in Stable Renal Allograft Recipients - NCT00713284
    Visit the Renal Allograft Recipients study on ClinicalTrials.gov.    		 Subjects who are either scheduled to or have recently (within 7 days) had a kidney transplant Open
    Principal Investigator:
    Kimi Ueda, PharmD

    Contact:
    Jennifer Wilson
    415-600-1155
    Email WilsonJX@cpmcri.org     		A Double-Blind, Randomized, Stratified, Multi-center Trial Evaluating Conventional and High Dose Oseltamivir in the Treatment of Immunocompromised Patients with Influenza - NCT00545532
    Visit the Influenza study on ClinicalTrials.gov.    		Kidney transplant recipients who may be infected with the influenza virus (the flu)Open
    Principal Investigator:
    Parul Patel, MD

    Contact:
    Jennifer Wilson
    415-600-1155
    Email WilsonJX@cpmcri.org    		 A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus-NCT00502242
    Visit the Maintenance Renal Transplant Patients Converted to Sirolimus study on ClinicalTrials.gov.    		Kidney transplant recipients with well controlled blood pressure and who are currently taking either tacrolimus or cyclosporine to prevent rejection of transplanted kidney Open
    Principal Investigator:
    Ram Peddi, MD

    Contact:
    Jennifer Wilson
    415-600-1155
    Email WilsonJX@cpmcri.org    		 Bio-archive in Recipients of Kidney Transplants (RKIVE) Subjects who are scheduled to or have recently had a kidney transplant Open
    Principal Investigator:
    Ram Peddi, MD

    Contact:
    Jennifer Wilson
    415-600-1155
    Email WilsonJX@cpmcri.org    		 A Phase 2 Randomized, Multicenter, Active Comparator-Controlled Trial To Evaluate The Safety And Efficacy Of Co-administration Of CP-690,550 And Mycophenolate Mofetil / Mycophenolate Sodium In De Novo Kidney Allograft Recipients –JAK 3-NCT00483756
    Visit the Kidney Allograft Recipients study on ClinicalTrials.gov.    		 Subjects who are scheduled to have a kidney transplant (within 30 days)Closed to Enrollment


    updated 8/22/2010